Email Page Print Page

SEC Filings and Financial Information

Select the filing type and date range you wish to view from the drop-down menus below.

NASDAQBDSI
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesDec 26, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 21, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 21, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 20, 2012View HTMLDownload DOCDownload PDF
SC 13GSchedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutionsDec 10, 2012View HTMLDownload DOCDownload PDFDownload XLS
SC 13GSchedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutionsDec 6, 2012View HTMLDownload DOCDownload PDFDownload XLS
SC 13GSchedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutionsDec 4, 2012View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventDec 3, 2012View HTMLDownload DOCDownload PDFDownload XLS
424B3Form of prospectus reflecting facts events constituting substantive change from last formNov 28, 2012View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventNov 28, 2012View HTMLDownload DOCDownload PDFDownload XLS
424B3Form of prospectus reflecting facts events constituting substantive change from last formNov 28, 2012View HTMLDownload DOCDownload PDFDownload XLS
10-QQuarterly report which provides a continuing view of a company's financial positionNov 9, 2012View HTMLDownload DOCDownload PDFDownload XLSView XBRLDownload XBRL
8-KReport of unscheduled material events or corporate eventNov 9, 2012View HTMLDownload DOCDownload PDFDownload XLS
424B3Form of prospectus reflecting facts events constituting substantive change from last formOct 22, 2012View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventOct 18, 2012View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventOct 15, 2012View HTMLDownload DOCDownload PDFDownload XLS
CT ORDERConfidential treatment orderOct 3, 2012View HTMLDownload DOCDownload PDF
SC 13G/AAmendment to a previously filed SC 13GOct 1, 2012View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesSep 27, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 27, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 27, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 27, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 27, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 20, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 20, 2012View HTMLDownload DOCDownload PDF
1-25      26-50      51-75      76-78
Top News
Oct 12, 2017

BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a specialty pharmaceutical company with a focus in pain management and addiction medicine, today announced that it has entered into a...

Oct 6, 2017

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) participated in a round table meeting convened this week in Washington, D.C. by the U.S. Department of Health and Human Services (HHS) to...

Sep 19, 2017

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that Dr. Mark A. Sirgo, Vice Chairman, President and Chief Executive Officer, will present at two upcoming healthcare conferences....

investor inquiries

 

Al Medwar
Senior Vice President, Corporate and Business Development
BioDelivery Sciences International, Inc.
919-582-9050
amedwar@bdsi.com